Stay updated on Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer/history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThis update only adds Revision: v3.3.2 and removes Revision: v3.2.0 from the study's version history, with no changes to study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe funding/operating-status notice at the top of the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedA minor metadata update was made: a new Study Status References entry was added on 2025-10-22 and an entry was removed on 2025-10-17. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check79 days agoChange DetectedUpdate includes a new date stamp and study status tag, replacing an older timestamp. Overall meaning shifts toward current context and status rather than substantive content changes.SummaryDifference0.9%

- Check93 days agoChange DetectedThe page has been updated to announce a government funding lapse affecting operations with a note that NIH Clinical Center is open, plus a version bump to v3.2.0, replacing the prior v3.1.0.SummaryDifference9%

Stay in the know with updates to Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.